| Bioactivity | Hc-CATH (Sea snake cathelicidin) is an antibacterial peptide with broad-spectrum. Hc-CATH inhibits Shigella dysenteriae and Klebsiella pneumoniae with MIC of 0.16 mM-20.67 mM. Hc-CATH exhibits anti-inflammatory efficacy[1]. |
| CAS | 1801534-21-3 |
| Sequence | Lys-Phe-Phe-Lys-Arg-Leu-Leu-Lys-Ser-Val-Arg-Arg-Ala-Val-Lys-Lys-Phe-Arg-Lys-Lys-Pro-Arg-Leu-Ile-Gly-Leu-Ser-Thr-Leu-Leu |
| Shortening | KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL |
| Formula | C171H300N52O34 |
| Molar Mass | 3628.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Semreen MH, et al., Recent updates of marine antimicrobial peptides. Saudi Pharm J. 2018 Mar;26(3):396-409. |
Hc-CATH
CAS: 1801534-21-3 F: C171H300N52O34 W: 3628.54
Hc-CATH (Sea snake cathelicidin) is an antibacterial peptide with broad-spectrum. Hc-CATH inhibits Shigella dysenteriae
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.